This Week's Poll

At the recent BioPartner Forum it was stated the internal market is insufficient for a UK Life Science company to develop a technology, product or service at a rate that will return investor value. Do you

Supported by Medilink UK

West Midlands Task and Finish Group - Dr David Gleaves of - MidTECH - 8:20:43am Jun-24th

The Regional Task and Finish Group has made the following recommendations for medical technologies in the West Midlands: 1)create a specialist tendering and sales support service; 2)integrate regional support mechanisms; 3)articulate clear, consistent messages describing the region's capabilities and support mechanisms to promote the region. Is there anything we've missed which you would like to see included?

Agree/Disagree + add comment
 
 
t